본문 바로가기
대메뉴 바로가기
open
멈춤
시작
이전
다음
오늘 하루 열지 않기
Close
SiteMap
Login
전체메뉴
Professor
Members
PhD student
M.S. student
Research associate
Alumni
Work
Research Project
Cancer cachexia research
Sarcopenia research
Tumor microenvironment research
Drug development projects
Publication
Community
Research news
Bulletin board
Patent
Lab album
Journal club
SiteMap
Login
New Drug Targets Laboratory
Professor
Members
PhD student
M.S. student
Research associate
Alumni
Work
Research Project
Cancer cachexia research
Sarcopenia research
Tumor microenvironment research
Drug development projects
Publication
Community
Research news
Bulletin board
Patent
Lab album
Journal club
닫기
Community
Journal club
HOME
Community
Journal club
프린트
Sorafenib exerts an anti-keloid activity by antagonizing TGF-β Smad and MAPK ERK signaling pathways
작성자
박지영
조회수
537
Date
2020-09-17
Sorafenib exerts an anti-keloid activity by antagonizing TGF-β Smad and MAPK ERK signaling pathways.pdf [7,940.4 KB]
공공저작물 자유이용 허락 표시
공공누리 2유형 출처표시 + 상업적 이용금지
저작권 보호분야
Sorafenib exerts an anti-keloid activity by antagonizing TGF-β Smad and MAPK ERK signaling pathways
저작물은 공공누리 출처표시 조건에 따라
공공누리 2유형
출처표시 + 상업적 이용금지
이용할 수 있습니다.
다음글
Sestrin prevents atrophy of disused and aging muscles by integrating anabolic and catabolic signals
2020-09-25
이전글
Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia
2020-09-10
QUICK
MENU
GIST 대표
GIST Portal
생명과학부
도서관
증명서 발급